Patents expiring in 2040

US 10548953

Factor VIII-XTEN fusions and uses thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548890

Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

Platform Brightworks Two, Ltd. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548886

Methods of treatment using a JAK inhibitor compound

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548946

Therapeutic compositions for neutralizing type I interferons, and methods of use

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548962

Use of the salmonella SPP type III secretion proteins as a protective vaccination

The Board of Regents for Oklahoma State University · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548850

Therapeutic composition comprising insulin prepared for delivery into an intestinal tract

Rani Therapeutics, LLC · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548883

Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor

Medshine Discovery Inc. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550084

Substituted 1-hydroxy-pyridin-2(1H)-ones, and methods of making and using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548899

Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activity

Takeda Pharmaceutical Company Limited · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548860

HIF-1 modulator paint formulation and uses thereof

United States Government as represented by the Department of Veterans Affairs · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550081

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548984

RVG Derived peptides

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548954

Factor IX polypeptides and methods of use thereof

BIOVERATIV THERAPEUTICS INC. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548971

MERS-CoV vaccine

Inovio Pharmaceuticals, Inc. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548979

Light-activated compositions and methods using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548302

Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10548905

Amorphous onapristone compositions and methods of making the same

CONTEXT BIOPHARMA, INC. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550129

1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

Takeda Pharmaceutical Company Limited · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550118

JAK inhibitors containing a 4-membered heterocyclic amide

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550163

Peptide fragments of netrin-1 and compositions and methods thereof

The Regents of the University of California · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550157

Compositions and methods for treating central nervous system (CNS) disorders and mood disorders

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10550192

Antigen-binding proteins that antagonize leptin receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2020040086

PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY

BERLIN CHEMIE AG [DE] · Granted Thu Feb 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3103888

PROCEDE DE PURIFICATION DE SULFATE D'ISAVUCONAZONIUM

BASILEA PHARM INT AG [CH] · Granted Thu Feb 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555929

Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

Coherus BioSciences, Inc. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555961

Materials and methods for treating bacterial infections using C-1 gentamicin

United States Government as represented by the Department of Veterans Affairs · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556890

Heteroaryl compounds and methods of use thereof

PGI Drug Discovery LLC · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556021

Nanocarriers for drug delivery

The Regents of the University of California · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556897

Protein kinase inhibitors

Princeton Drug Discovery, Inc · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555964

Composition and method for promoting reduction of heat stress in animals

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556875

Bis-diazeniumdiolate compounds as anti-cancer agents

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555928

Cannabis extracts and methods of preparing and using same

United Cannabis Corp. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556916

Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556861

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS, INC. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556256

Antibacterial water

Takeda Pharmaceutical Company Limited · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556881

Nrf2 activating compounds and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555963

Klotho protein and related compounds for the treatment and diagnosis of cancer

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556001

Thermal inactivation of rotavirus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556860

hTERT modulators and methods of use

THE ARIZONA BOARD OF REGENTS · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556891

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10557137

Modulating apolipoprotein (a) expression

Ionis Pharmaceuticals, Inc. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10557118

Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556940

T cell receptors recognizing HLA-Cw8 restricted mutated KRAS

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556892

Piperazinyl methanone NAAA inhibitors

The Regents of the University of California · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555997

Antigens and vaccines directed against human enteroviruses

SENTINEXT THERAPEUTICS Sdn Bhd · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555942

Emetine compounds for treatment and prevention of flavivirus infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10555960

Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10556945

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)